KLOW's clean tolerability is a large part of why it is the blend most people start with; Ascension's 80mg vial is third-party tested per batch.
Side Effects by Component
Understanding which peptide is causing what helps you troubleshoot. Here's the breakdown:
BPC-157 — What It Can Cause
- Mild nausea (dose-dependent, usually at higher doses)
- Brief dizziness after injection
- Injection site soreness
TB-500 — What It Can Cause
- Mild fatigue in first 1–2 weeks
- Temporary headache
- Very rarely: mild nausea at high doses
GHK-Cu — What It Can Cause
- Injection site redness (mild, hours only)
- Temporary skin darkening at application site (topical only)
- Mild tingling at injection site
KPV — What It Can Cause
- One of the most well-tolerated peptides — side effects are extremely rare
- Mild injection site reaction
Overall KLOW Side Effect Profile
In practice, most people running KLOW don't separate out which peptide is responsible for what they feel — and for most users, the answer is: not much. The combination has a clean safety profile. The peptides in KLOW have overlapping mechanisms (healing, anti-inflammatory) and no known adverse interactions with each other.
- Spreading redness, warmth, or fever at injection site (infection)
- Severe or persistent nausea
- Allergic reaction: hives, swelling, difficulty breathing
Tips to Minimize Side Effects
- Start at a lower volume — if you're new to peptides, your first week at 50–75% of target dose lets your body adjust
- Rotate injection sites — abdomen, outer thigh, flank
- Inject slowly — reduces local irritation significantly
- Morning injection — avoids sleep disruption if you're sensitive
- Stay hydrated — reduces most injection-related systemic effects
Who Should Not Use KLOW
- People with active cancer (GHK-Cu promotes angiogenesis; BPC-157 has similar theoretical concern)
- Those with Wilson's disease or copper metabolism disorders (GHK-Cu component)
- Pregnant or breastfeeding women
- Competitive athletes subject to WADA testing (TB-500 is prohibited)
Outside those groups, KLOW has one of the mildest side effect profiles of any blend — most users report nothing beyond first-week injection site soreness.
Frequently Asked Questions
Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. All peptides mentioned are research compounds not approved by the FDA for human use. Always consult a qualified healthcare provider before starting any peptide protocol. PeptideDeck may earn a commission from affiliate links at no additional cost to you.
